PURPOSE: A heterocycle derivative used in manufacturing a medicine for treating uric acid-associated diseases is provided to ensure selectivity between organic anion transporters and high solubility and metabolic stability. CONSTITUTION: A heterocycle derivative compound has a structure of chemical formula I. A method for preparing a compound of chemical formula II or racemic body, isomer or pharmaceutically acceptable salt thereof comprises: a step of reducing a compound of chemical formula VII to obtain a compound of chemical formula VI; a step of cyclizing the compound of chemical formula VI and a compound of chemical formula V to obtain a compound of chemical formula IV; and a step of performing peptide bond of the compound of chemical formula IV and a compound of chemical formula III to obtain a compound of chemical formula II. A pharmaceutical composition contains the heterocycle derivative compound or racemic body, isomer or pharmaceutically acceptable salt thereof and pharmaceutically acceptable carrier. The pharmaceutical composition is formulated in oral administration.
申请公布号
KR20110005688(A)
申请公布日期
2011.01.18
申请号
KR20107021818
申请日期
2009.03.31
申请人
C.& C. RESEARCH LABS. CO.
发明人
AHN, SUNG OH;PARK, CHAN HEE;IM, JUN HWAN;LEE, SOON OK;LEE, KYOUNG JUNE;CHO, SEONG WOOK;KO, KWANG SEOK;HAN, SUN YOUNG;LEE, WON IL